NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,816 | +181.6% | 1,246 | +290.6% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 319 | -37.5% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 510 | -13.7% | 0.00% | -100.0% |
| Q4 2021 | $8,000 | – | 591 | +2173.1% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 26 | -86.5% | 0.00% | -100.0% |
| Q2 2021 | $3,000 | +200.0% | 192 | +638.5% | 0.00% | – |
| Q1 2021 | $1,000 | – | 26 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 26 | -91.4% | 0.00% | -100.0% |
| Q3 2020 | $5,000 | -28.6% | 301 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $7,000 | +133.3% | 301 | +84.7% | 0.00% | +200.0% |
| Q1 2020 | $3,000 | -40.0% | 163 | -28.5% | 0.00% | -50.0% |
| Q4 2019 | $5,000 | +25.0% | 228 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $4,000 | -60.0% | 228 | -17.1% | 0.00% | -60.0% |
| Q2 2019 | $10,000 | +25.0% | 275 | +13.6% | 0.01% | +25.0% |
| Q1 2019 | $8,000 | 0.0% | 242 | +5.7% | 0.00% | 0.0% |
| Q4 2018 | $8,000 | -38.5% | 229 | +6.0% | 0.00% | -20.0% |
| Q3 2018 | $13,000 | +44.4% | 216 | +12.5% | 0.01% | +25.0% |
| Q2 2018 | $9,000 | -55.0% | 192 | 0.0% | 0.00% | -55.6% |
| Q1 2018 | $20,000 | +81.8% | 192 | 0.0% | 0.01% | +80.0% |
| Q4 2017 | $11,000 | +120.0% | 192 | 0.0% | 0.01% | +150.0% |
| Q3 2017 | $5,000 | +25.0% | 192 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $4,000 | -20.0% | 192 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $5,000 | +150.0% | 192 | 0.0% | 0.00% | +200.0% |
| Q4 2016 | $2,000 | – | 192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |